Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Repare Therapeutics Inc. - Common Shares (NQ:RPTX)

2.130 -0.050 (-2.29%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 467,496
Open 2.180
Bid (Size) 2.100 (41,800)
Ask (Size) 2.140 (4,000)
Prev. Close 2.180
Today's Range 2.100 - 2.180
52wk Range 0.8900 - 4.069
Shares Outstanding 42,088,446
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Halper Sadeh LLC Encourages RPTX, THS, RMBI Shareholders to Contact the Firm to Discuss Their Rights
Shareholders should contact the firm immediately as there may be limited time to enforce your rights 
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
Repare Therapeutics Enters into Support and Voting Agreements with Significant Shareholders for Proposed Transaction with XenoTherapeutics, Inc.
From Repare Therapeutics Inc.
Via Business Wire

Performance

YTD
+61.4%
+61.4%
1 Month
+15.8%
+15.8%
3 Month
+25.3%
+25.3%
6 Month
+55.5%
+55.5%
1 Year
-33.4%
-33.4%

More News

Read More
News headline image
In today's session, these stocks are experiencing unusual volume. ↗
Via Chartmill
Repare Therapeutics Jumps After Hours On $267M Global Licensing Deal With Debiopharm; Retail Traders Rush In ↗
Via Stocktwits
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
Via Benzinga
News headline image
Halper Sadeh LLC Encourages RPTX and SEE Shareholders to Contact the Firm to Discuss Their Rights
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
The market is filled with gapping stocks in Monday's session. ↗
Via Chartmill
News headline image
Repare Therapeutics Agrees To Acquisition As Board Cites Best Path For Stakeholder Value ↗
Via Benzinga
News headline image
These stocks are moving in today's pre-market session ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
Via Benzinga
News headline image
Why Quantum Computing Shares Are Trading Higher By Over 23%; Here Are 20 Stocks Moving Premarket ↗
Via Benzinga
News headline image
RPTX Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Repare Therapeutics Inc. is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
News headline image
Repare Therapeutics Enters into Definitive Agreement to be Acquired by XenoTherapeutics, Inc.
From Repare Therapeutics Inc.
Via Business Wire
News headline image
Repare Therapeutics to Present Initial Data from Phase 1 LIONS Clinical Trial at 37th AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
From Repare Therapeutics Inc.
Via Business Wire
News headline image
Repare (RPTX) Q2 Loss Narrows 52% ↗
Via The Motley Fool
News headline image
Repare Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results
From Repare Therapeutics Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
Via Benzinga
News headline image
Why Data Storage Shares Are Trading Higher By 35%; Here Are 20 Stocks Moving Premarket ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
Via Benzinga
News headline image
Tuesday's after hours session: top gainers and losers ↗
Via Chartmill
News headline image
Repare Therapeutics Enters Exclusive Worldwide Licensing Agreement with Debiopharm for Lunresertib
From Repare Therapeutics Inc.
Via Business Wire
News headline image
Repare Therapeutics Provides Business and Clinical Update and Reports First Quarter 2025 Financial Results
From Repare Therapeutics Inc.
Via Business Wire
News headline image
Repare Therapeutics Announces Out-Licensing of its Discovery Platforms to DCx Biotherapeutics
From Repare Therapeutics Inc.
Via Business Wire
News headline image
Repare Therapeutics Announces Six Abstracts Accepted for Presentation at AACR Annual Meeting 2025
From Repare Therapeutics Inc.
Via Business Wire
News headline image
Cathie Wood's Ark Invest Offloads Uipath, Prime Medicine, And Repare Therapeutics ↗
Via Benzinga

Frequently Asked Questions

Is Repare Therapeutics Inc. - Common Shares publicly traded?
Yes, Repare Therapeutics Inc. - Common Shares is publicly traded.
What exchange does Repare Therapeutics Inc. - Common Shares trade on?
Repare Therapeutics Inc. - Common Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Repare Therapeutics Inc. - Common Shares?
The ticker symbol for Repare Therapeutics Inc. - Common Shares is RPTX on the Nasdaq Stock Market
What is the current price of Repare Therapeutics Inc. - Common Shares?
The current price of Repare Therapeutics Inc. - Common Shares is 2.130
When was Repare Therapeutics Inc. - Common Shares last traded?
The last trade of Repare Therapeutics Inc. - Common Shares was at 12/01/25 04:00 PM ET
What is the market capitalization of Repare Therapeutics Inc. - Common Shares?
The market capitalization of Repare Therapeutics Inc. - Common Shares is 89.65M
How many shares of Repare Therapeutics Inc. - Common Shares are outstanding?
Repare Therapeutics Inc. - Common Shares has 90M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.